Vaccine approval

FDA Vaccine Protocol: Experts Decry New Standards as Dangerous

The FDA’s leading vaccine regulator has announced stricter approval processes, citing a review that linked Covid vaccines to the deaths of at least ten children, primarily due to myocarditis. This shift involves re-evaluating existing vaccination policies, potentially limiting simultaneous vaccinations, and demanding more robust safety data. Experts suggest these changes could significantly slow the vaccine approval pipeline and may even discourage innovation in vaccine research. Critics, including former FDA officials and independent scientists, question the lack of detailed evidence supporting these claims and the potential politicization of the agency’s approach, emphasizing the importance of thorough investigation and peer review.

Read More

FDA Official’s Restrictions on COVID Vaccines Spark Controversy, Raise Questions

Newly released FDA documents reveal that the government’s top vaccine official, Dr. Vinay Prasad, under Health Secretary Robert F. Kennedy Jr., restricted the approval of two COVID-19 vaccines, Novavax and Moderna, overriding recommendations from government scientists. These scientists had initially planned to approve the shots for individuals 12 and older, concluding the benefits outweighed the risks. However, Prasad decided to limit the vaccines to those at higher risk, such as seniors and those with underlying medical conditions, citing concerns about potential side effects and reconsidering the benefits in light of changing infection rates. This decision is part of a series of vaccine restrictions imposed by officials under Kennedy.

Read More